Search result for 'glaxosmithkline pharmaceuticals'

GlaxoSmithKline Pharmaceuticals shares jumped 16% after reporting a five-fold increase in net profit for the third quarter, reaching Rs 229 crore. The strong performance was driven by increased...

GlaxoSmithKline Pharmaceuticals reports a five-fold jump in net profit for the third quarter ending December 31, 2024, reaching Rs 229 crore. Revenue also increased to Rs 949 crore.

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments. Key brands like Augmentin and Nucala saw growth.

GlaxoSmithKline Pharmaceuticals's net profit fell 72% to Rs 46 crore in Q3, while revenue increased to Rs 833 crore. The company is focusing on new categories like adult immunisation.